Adimmune Balance Sheet Health
Financial Health criteria checks 4/6
Adimmune has a total shareholder equity of NT$5.8B and total debt of NT$3.1B, which brings its debt-to-equity ratio to 53.3%. Its total assets and total liabilities are NT$9.5B and NT$3.7B respectively.
Key information
53.3%
Debt to equity ratio
NT$3.08b
Debt
Interest coverage ratio | n/a |
Cash | NT$2.47b |
Equity | NT$5.78b |
Total liabilities | NT$3.71b |
Total assets | NT$9.48b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 4142's short term assets (NT$4.7B) exceed its short term liabilities (NT$1.8B).
Long Term Liabilities: 4142's short term assets (NT$4.7B) exceed its long term liabilities (NT$1.9B).
Debt to Equity History and Analysis
Debt Level: 4142's net debt to equity ratio (10.5%) is considered satisfactory.
Reducing Debt: 4142's debt to equity ratio has reduced from 191.8% to 53.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 4142 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 4142 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.